DUSA Pharmaceuticals (DUSA) Posts Higher Earnings, Wider Net Loss

QualityStocks would like to highlight DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA), an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan(R) PDT technology platform, and other dermatology products.

In the company’s news today,

DUSA Pharmaceuticals reported a 27 percent increase in first-quarter revenues.

“We are off to a great start in 2011,” Robert Doman, president and CEO of the DUSA stated in the press release. “Continued growth of our core domestic PDT revenues, as well as record gross margins, drove significant year-over-year improvement in our non-GAAP profitability and cash flow.”

Total product revenues for the first quarter were $11.1 million, up 27 percent from $8.7 million in the first quarter of 2010.

The company reported a net loss of $0.6 million, or $(0.02) per common share, for the first quarter of 2011, compared to a net loss of $0.4 million, or $(0.02) per common share, in the first quarter of 2010.

As of March 31, 2011, the company reported total cash, cash equivalents, and U.S. government securities of $21.1 million, compared to $19.6 million at December 31, 2010, an increase of $1.4 million during the quarter.

“As the year progresses, we remain focused on building upon the momentum we have created in the marketplace by further leveraging our expanding sales force in an effort to increase market penetration and acceptance of Levulan® PDT,” Doman stated.


About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.